[SERMs for treatment of osteoporosis: state-of-the-art and perspectives].

Gynecologie, obstetrique & fertilite 2006 Vol.34(5) p. 423-8

Legrand E, Hoppé E, Chappard D, Audran M

관련 도메인

Abstract

Every year in France, we observe 60,000 vertebral fractures, 50,000 hip fractures and 35,000 wrist fractures. However, only 20% of these patients receive adequate pharmacologic therapy to prevent new fractures and their complications. At the present time, clinicians have not a perfect knowledge of the therapeutic class of SERMs (Selective Estrogen Receptor Modulators). In this paper, the authors show the strong capacity of these drugs to produce, in osteoporotic postmenopausal women, major therapeutic effects on bone (reduction of fracture risk), on breast (reduction of cancer risk), and without any side effects on arterial diseases except an increased risk of venous thromboembolism.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 1
해부 bone scispacy 1
약물 SERMs → Selective Estrogen Receptor Modulators C0732611
Selective Estrogen Receptor Modulators
scispacy 1
질환 osteoporosis C0029456
Osteoporosis
scispacy 1
질환 fractures C0016658
Fracture
scispacy 1
질환 fracture C0016658
Fracture
scispacy 1
질환 breast (reduction of cancer scispacy 1
질환 venous thromboembolism C1861172
Venous Thromboembolism
scispacy 1
질환 osteoporotic postmenopausal women scispacy 1
질환 cancer scispacy 1
기타 SERMs → Selective Estrogen Receptor Modulators scispacy 1
기타 arterial scispacy 1

MeSH Terms

Breast Neoplasms; Female; Fractures, Bone; France; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문